Elizabeth Glynn Nilson, M.D. Preventive Medicine - Public Health & General Preventive Medicine Medicare: Accepting Medicare Assignments Practice Location: 67 S Bedford St Ste 202e, Burlington, MA 01803 Phone: 781-744-7000 Fax: 781-744-7516 |
Dr. Darryl D Esakof, MD Preventive Medicine - Clinical Informatics Medicare: Accepting Medicare Assignments Practice Location: 41 Mall Road, Department Of Cardiovascular Medicine, Lahey Clinic, Burlington, MA 01805 Phone: 781-744-8461 Fax: 781-744-5261 |
News Archive
A new article published in the American Journal of Hypertension finds that babies born to mothers with cardiometabolic risk factors were less likely to develop high blood pressure if their mothers had higher levels of folate during pregnancy.
Physicians using Greenway Medical Technologies' electronic health record (EHR) solution, PrimeSuite, now have access to lab results, radiology reports and transcribed documents from their community health system through RelayHealth's Virtual Information Exchange platform.
Health-conscious people know that high levels of total cholesterol and LDL cholesterol (the so-called "bad" cholesterol) can increase the risk of heart attacks. Now scientists are reporting that another form of cholesterol called oxycholesterol - virtually unknown to the public - may be the most serious cardiovascular health threat of all. Scientists from China presented one of the first studies on the cholesterol-boosting effects of oxycholesterol here today at the 238th National Meeting of the American Chemical Society. The researchers hope their findings raise public awareness about oxycholesterol, including foods with the highest levels of the substance and other foods that can combat oxycholesterol's effects.
According to new research, men screened for prostate cancer using blood tests or digital examinations die of the disease at much the same rate as those who were not checked.
Ontario has taken a major step forward in access to treatment for patients in the province with advanced kidney cancer by granting coverage for TORISELTM (temsirolimus), for advanced renal cell carcinoma (RCC) with poor prognostic features.
› Verified 5 days ago